Contemporary and optimal medical management of peripheral arterial disease. Surg Clin North Am 2013 Aug;93(4):761-78, vii
Date
07/28/2013Pubmed ID
23885930DOI
10.1016/j.suc.2013.04.009Scopus ID
2-s2.0-84880699753 (requires institutional sign-in at Scopus site) 5 CitationsAbstract
Atherosclerotic lower extremity peripheral arterial disease (PAD) is a highly prevalent condition associated with a significant increase in risk of all-cause mortality and cardiovascular morbidity and mortality. PAD is underdiagnosed and undertreated. Treatment is focused on (1) lowering cardiovascular risk and cardiovascular disease event rates and (2) improvement in symptoms and quality of life. Multidisciplinary and intersociety guidelines guide optimal medical therapy. Substantial evidence supports implementation of tobacco cessation counseling and pharmacotherapy to help achieve tobacco abstinence, antiplatelet therapy, HMG-CoA reductase inhibitors (statins) therapy, and antihypertensive therapy for the purpose of lowering cardiovascular event rates and improving survival.
Author List
Tattersall MC, Johnson HM, Mason PJAuthor
Peter Mason MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antihypertensive AgentsAtherosclerosis
Diabetic Angiopathies
Early Diagnosis
Exercise Therapy
Humans
Hyperlipidemias
Hypertension
Hypolipidemic Agents
Life Style
Peripheral Vascular Diseases
Platelet Aggregation Inhibitors
Practice Guidelines as Topic
Risk Factors
Smoking
Smoking Cessation